Joint Commission-Hospital Collaboration Targets Hand-Offs


Published On: October 22nd, 2010

The ten hospitals and systems that volunteered to collaborate on the issue initially found that hand-offs were defective 37% of the time.

The rest is here:
Joint Commission-Hospital Collaboration Targets Hand-Offs

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


Female breast cancer: Incidence rose between 1980 and 2001, then began to fall through 2005.

Related Posts

  • Which Drug Companies Could Be Private-Equity Targets?
    The recent $4 billion private-equity buyout of IMS Health raises an irresistible question: What other health-care companies might catch private equity’s eye? ..
  • FDA Targets Fake Web Claims for H1N1 Products
    Regulators are taking aiming at companies marketing products on the Internet that claim to diagnose, treat, prevent or cure the H1N1 flu virus. ..
  • Joint Replacement Trends in Younger Generations
    Hard charging baby boomers and Generation X-ers are wearing out their joints at younger ages and turning to joint replacement surgery - but is it a quick fix? WSJ’s health columnist Melinda Beck discusses with Kelsey Hubbard. ..
  • Amgen, GSK to Launch Joint Sales Attack for Bone Drug
    Amgen may want to avoid the “ carpet-bombing approach ” to selling its new osteoporesis drug denosumab , but it is upping its sales firepower by partnering with pharmaceutical giant GlaxoSmithKline to market the therapy, the companies announced today. The biotech had said last year it was dropping the approach of fielding as many sales..
  • Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study
    A year ago, eight companies, including several fierce rivals, announced plans for an unusual $100 million study to address a huge question plaguing the market for artery-opening devices called coronary stents: How long do patients need to take blood-thinning drugs to prevent rare but life-threatening blood clots from re-clogging the devices. Now, the companies are..
  • Joint Commission to Help Hospitals Fix, Not Just Identify, Problems
    To win accreditation from the Joint Commission , hospitals pay a fee to be evaluated on how well they meet patient safety standards. ..
Leave a comment
Comments are closed.
« Pushing Fruits and Veggies With Junk Food Tactics Insurance Brokers Lose Out in Final NAIC Recommendations »